Sulfated polysaccharides are capable of binding with proteins at several levels of specifi city. As highly acidic macromolecules, they can bind non-specifi cally to any basic patch on a protein surface at low ionic strength, and such interactions are not likely to be physiologically signifi cant. On the other hand, several systems have been identifi ed in which very specifi c substructures of sulfated polysaccharides confer high affi nity for particular proteins; the best-known example of this is the pentasaccharide in heparin with high affi nity for antithrombin, but other examples may be taken from the study of marine invertebrates: the importance of the fi ne structure of dermatan sulfate (DS) to its interaction with heparin cofactor II (HCII), and the involvement of sea urchin egg-jelly fucans in species specifi c fertilization. A third, intermediate, kind of specifi c interaction is described for the cell-surface glycosaminoglycan heparan sulfate (HS), in which patterns of sulfate substitution can show differential affi nities for cytokines, growth factors, and morphogens at cell surfaces and in the intracellular matrix. This complex interplay of proteins and glycans is capable of influencing the diffusion of such proteins through tissue, as well as modulating cellular responses to them.
Sulfated polysaccharides are found throughout the animal kingdom (Dietrich et al. 1989 , Medeiros et al. 2000 and in some plants. They have diverse functions in their tissues of origin, and have more or less complex and often heterogeneous structures. They are not easy subjects for structural determination. Their large, acidic sulfate substituents dominate the physical characteristics of the isolated and purifi ed compounds, and can equally dominate the E-mail: bmulloy@nibsc.ac.uk effects of such preparations in biological systems. It is inevitable that these most acidic of biological macromolecules will be attracted to, and affect the activity of, any basic protein. There is no doubt that such interactions can lead to potent but non-specifi c biological activities, leading to skepticism of claims that important physiological processes may depend on subtle and specifi c distinctions between structures found in sulfated polysaccharides (Jones et al. 2004 ). There is, however, an increasing body of evidence that differences in patterns of sulfation along a polysaccharide are involved in recognition events, often outside the cell, and often involving
INTERACTIONS WITH STRONG SPECIFICITY

HEPARIN AND ANTITHROMBIN
The GAG heparin has been the most commercially and therapeutically important sulfated polysaccharide. For the fi rst 30 years of its clinical use, not much was known about its structure except that it was composed of glucosamine and uronic acid, with heavy sulfate substitution (Petitou et al. 2003) . Heparin has very much higher specifi c activity as an anticoagulant than other sulfated polysaccharides, due to its ability to potentiate the plasma serine protease inhibitor antithrombin. Efforts to purify heparin, in trying to achieve the highest possible sulfate content, in fact reduced its potency.
At about the same time, methods for structural determination of carbohydrates were under rapid development. The main repeating structure of heparin was established as a disaccharide of alternating N -and 6-O-sulfated α-D-glucosamine and 2-Osulfated α-L-iduronic acid (Perlin et al. 1971) , with a minor proportion of N -acetyl glucosamine and β-D-glucuronic acid. (Figs. 1A, 1B ) Determination of the structural motif in heparin with high affi nity for antithrombin came, after years of painstaking work, from groups in France, Sweden, Italy and the USA (Petitou et al. 2003) . This pentasaccharide sequence (Fig. 1C) is unusual, and is not found in every heparin molecule. Features essential to its affi nity with antithrombin are indicated in the fi gure; the most striking of these is the 3-O-sulfated glucosamine (also N -sulfated and 6-O-sulfated) at the center of the oligosaccharide. The structure illustrated was confi rmed by synthesis; the synthetic pentasaccharide has a high anticoagulant activity (Choay et al. 1983) , and a version of this compound is now in use as an antithrombotic agent. Eventually the crystal structure of antithrombin with a heparin-like synthetic pentasaccharide bound to it was solved, and interactions mapped in great detail (Jin et al. 1997) (Fig. 2) .
The high specifi city of this interaction was unexpected. However, as a paradigm for heparin's other biological activities, the antithrombin system has not been successful; only in a few cases have unusual sequences been found with narrow preferences for their protein ligands. For example a 3,6-O-sulfated, N -unsubstituted glucosamine is characteristic of the receptor sequence for herpes simplex virus type 1 glycoprotein D (Liu et al. 2002 , Shukla et al. 1999 . In an interesting development, a 3-O-sulfated heparan sulfate motif has recently been found in the pineal gland, predominantly during daylight hours (Kuberan et al. 2004) .
Other examples of specifi c interactions between proteins and sulfated polysaccharide structures have however come from studies of marine organisms, always a rich source of unusual and interesting structures.
DERMATAN SULFATES AND HEPARIN COFACTOR II
Another mammalian glycosaminoglycan, dermatan sulfate (DS), has mild anticoagulant activity through its potentiation of heparin cofactor II (HCII), which, like antithrombin, is a plasma serine protease inhibitor. Mammalian dermatan sulfate has the structure shown in Fig. 3a , a disaccharide consisting of alternating 4-O-sulfated galactosamine and (for the most part) unsulfated iduronate residues. The DS sequence with high affi nity for HCII, however, is sulfated not only at the 4-position of GalNAc, but in addition at the 2-position of IdoA (Maimone and Tollefsen 1990) (Fig. 3b ). This sequence has a level of substitution twice that of the predominant repeat unit. Heparin, with three sulfates per disaccharide, also activates HCII; this at fi rst sight is an example of a non-specifi c system in which density of sulfate substitution determines binding.
A dermatan sulfate-like compound from the marine invertebrate species Ascidia nigra was isolated and found to have O-sulfation at GalNAc C6 and IdoA C2 (Fig. 3c) (Mourão et al. 1997 , Pavão et al. 1995 This DS-like molecule is much more highly sulfated than mammalian DS, but is not ca- 
which is the minimal structure with high affi nity for antithrombin, the serine protease in plasma which inhibits several coagulation enzymes. The substituents essential for this affi nity are marked with an asterisk. pable of activating HCII, and has no measurable anticoagulant activity. Dermatan sulfates from two other ascidian species, Halocynthia pyriformis and Styela plicata, are both composed predominantly of the structure in Fig. 2b , and as might be expected have anticoagulant activity higher than that of mammalian DS (Pavão et al. 1998) .
It is therefore quite clear that, in the interaction between DS and HCII, it is the positions of the sulfate groups which are important, not merely the density of substitution.
SULFATED FUCANS AS DETERMINANTS OF SPECIES SPECIFICITY IN SEA URCHINS
Sulfated fucans constitute an interesting group of polysaccharides; algal fucoidans are complex in structure, though a few studies have found regular repeating structures underlying their heterogeneity. These plant polysaccharides are abundant in coastal waters all over the world, and have been suggested as alternatives to heparin in that they share many biological activities (Berteau and Mulloy 2003) .
Marine echinoderms, on the other hand, produce fucans which are linear homopolymers of fucose, with a single linkage type, onto which a regular repeating oligosaccharide structure is imposed by varying substitution with sulfate groups (Fig. 4 ): one such has been isolated from sea cucumber wall (Ribeiro et al. 1994 ) and several others from the egg jelly of various sea urchin species (Mulloy et al. 1994b) . It was noted that their structures are largely species specifi c (Fig. 3) . Egg jelly fucans are involved in the acrosome reaction, a morphological change in the sperm necessary for fertilization of the egg. The fucan of each species was found to induce the acrosome reaction only in sperm from the same sea-urchin species; and so play a part in the species specifi city of fertilization (Alves et al. 1997 , Hirohashi et al. 2002 . Some species have sub-populations with different fucan structures (Alves et al. 1998) . Sea urchins are free-spawning organisms, and species sharing the same waters need to ensure species-specifi c fertilization of their eggs. This simple variation in sulfated fucan structure is not the sole determinant, but is a major contributor. The structures of fucans from a few other species 
characteristic of ascidian dermatan sulfate, which does not confer any affi nity for heparin cofactor II at all. The affi nity of dermatan sulfate for heparin cofactor II depends not on sulfate content alone, but on the precise position of sulfate substitution. of sea urchin have been determined (Vilela-Silva et al. 1999 , but no doubt the oceans are full of many other as yet unknown structures. The anticoagulant activities and structures of algal and echinoderm fucans have been compared (Pereira et al. 1999 ).
INTERACTIONS OF INTERMEDIATE SPECIFICITY: HEPARAN SULFATE WITH GROWTH FACTORS AND MORPHOGENS
It is clear from the previous section that sulfated polysaccharides are capable of very specifi c, and physiologically important, interactions with proteins. The study of the sulfated glycan side-chains of proteoglycans, the glycosaminoglycans (of which both heparin and dermatan sulfate are members) has led recently to a more complex and subtle set of ideas about specifi city, in which the differential affi nities of proteins for various GAG sequences can affect the action of cytokines at the cell surface and can modulate their diffusion between cells. These properties are particularly relevant at times of change within tissues, for example during inflammatory episodes, in wound healing, and in embryonic development. Heparan sulfate (HS) consists of the same structural elements as heparin (indeed heparin is now regarded as a highly sulfated mast cell heparan sulfate). HS is almost ubiquitous as the glycosaminoglycan component of such proteoglycans as syndecans and glypicans on the surfaces of mammalian cells, and perlecan in the extracellular matrix. The GlcA-GlcNAc disaccharide makes up most of the structure of HS, interrupted by N -sulfated, iduronate-containing sequences known as S-regions. It is through these heparin-like S-regions that HS interacts with proteins. Conformational studies of heparin by NMR and molecular modeling have shown that the polysaccharide chain has a relatively well-defi ned shape, regardless of its pattern of sulfate substitution (Mulloy et al. 1993 (Mulloy et al. , 1994a (Fig. 5) . The sulfate substituents occur in clusters spaced at intervals of about 17Å down either side of the polysaccharide chain, each cluster consisting of one N -sulfate, one 2-O-sulfate, and one 6-O-sulfate, from three successive residues.
In the study of heparan sulfate-protein interactions, the more readily available heparin has been extensively used as a model compound, as fully sulfated heparin can occupy heparan sulfate binding sites with no loss of affi nity. The extra sul- fates do not interfere with binding. In the interaction between HS and a protein ligand, as long as the minimal specifi c motif of sulfate substitution in the HS S-region is present, different substitution patterns can be accommodated in the same binding site. This allows complex patterns of differential affi nities between proteins with different specifi cities and heparan sulfate sequences (Ashikari-Hada et al. 2004) . A further level of specifi city may be added in those interactions, usually involving protein oligomers, where two heparan sulfate S-regions are required for optimum affi nity, separated by a defi ned length of unsulfated, more flexible polysaccharide. This is the case for several chemokines such as platelet growth factor 4 Gallagher 1997), interleukin-8 (Lubineau et al. 2004) and MIP-1α (Stringer et al. 2002 (Stringer et al. , 2003 .
FIBROBLAST GROWTH FACTORS
Fibroblast growth factors (FGFs) I and II are probably the best studied ligands of heparin after antithrombin. Cell-surface heparan sulfate forms part of the receptor complex for these growth factors, and these two FGFs have different requirements in terms of heparan sulfate fi ne structure (Pye et al. 2000) . FGF-1 can act as an example of the class of proteins which has a preference for a specifi c pattern of sulfate substitution best defi ned not in terms of sequence but in terms of a spatial distribution of sulfate groups. Fig. 6a shows a detail of the of the heparin/ FGF-1 complex crystal structure (DiGabriele et al. 1998) . Two FGF-1 molecules bind to opposite faces of a heparin oligosaccharide. At fi rst sight this appears to be a symmetrical system, but in fact it is not; as is clear from Fig. 6b , one copy of FGF-1 binds with a sulfate cluster and an N -sulfate from the next cluster (towards the non-reducing end), whereas the other binds with a sulfate cluster and a 6-O-sulfate from the next cluster (towards the reducing end). The requirements of the FGF-1 heparin binding site can therefore be satisfi ed in more than one way.
This observation may be useful in the interpretation of binding data obtained, not from heparin, but from a library of octasaccharides derived from HS and separated by affi nity chromatography on immobilized FGF-1 (Jemth et al. 2002) . One feature, consistently associated with high affi nity by inspecting the sequences, is a trisaccharide motif (-IdoA2S-GlcNS6S-IdoA2S-) (Kreuger et al. 2001) . However when the sequences are presented in a simplifi ed three-dimensional format (Fig. 7) , it becomes clear that the motif of one complete cluster and one sulfate from the next cluster is present in high affi nity octasaccharides and absent in lower affi nity octasaccharides of the same overall A B Fig. 6 -FGF-1 and a heparin oligosaccharide: A: crystal structure of the complex (from coordinates in the PDB fi le 1AXM). Two copies of the FGF-1 monomer are depicted in a blue ribbon representation, with the heparin as in Fig. 5 ; B: An expansion of the area around the heparin molecule, with amino acid sidechains shown as thin sticks. Each of the FGF-1 molecules makes close contacts with sulfates in one complete cluster of three (see Fig. 5 ) and one or two sulfates from a subsequent cluster. The whole structure is not in fact symmetrical, and the two FGF-1 molecules are interacting with different sequences, but recognition depends in this case more strongly on a particular pattern of sulfates in three dimensions than on the sequence which presents that pattern. level of sulfate substitution. Synthetic heparin-like oligosaccharides with sulfate substitution along one 'side' only of the molecule are, as would be predicted from this reasoning, capable of binding to FGF-1; more surprisingly, they can also enhance its mitogenic activity (Angulo et al. 2004 ).
There are more than 20 known members of the fi broblast growth factor (FGF) family, most of which are predicted to have a conserved heparinbinding site (Venkataraman et al. 1999) . It has also been recognized that the individual isoform of the FGF receptor involved in the complex contributes to the specifi city of interactions with heparan sulfate, as has been demonstrated using a library of heparan sulfate oligosaccharides (Guimond and Turnbull 1999) and using chemically modifi ed heparins and heparin oligosaccharides (Lundin et al. 2000 , Ostrovsky et al. 2002 . Crystal structures have been determined for two FGF-FGFR-heparin ternary structures; FGF1-FGFR2-heparin decasaccharide (Pellegrini et al. 2000) and FGF2-FGFR1-heparin decasaccharide (Schlessinger et al. 2000) . Despite similarities between the components of the complexes, the two structures show some striking differences, for example predicting different stoichiometries and models for receptor dimerization (Pellegrini 2001) ; it has been suggested that both types of complex may be involved in the formation of extended signaling complexes on the cell surface (Harmer et al. 2004) . The numerous close heparinprotein contacts observed in the crystals have not allowed an unambiguous determination of minimal binding sequences. It has been pointed out that in addition to ionic interactions, shape complementarity influences specifi city; a " kink" may be observed in the polysaccharide on binding to FGF (Raman et al. 2003) .
HEPARAN SULFATE IN DEVELOPMENT
The example of the fi broblast growth factors demonstrates how the detailed three-dimensional structure of heparan sulfate allows for sequence variations which produce structural motifs capable of differential affi nities with growth factors and with growth factor/receptor pairs. This property may be an important factor in the space and time specifi c shaping of morphogen gradients during embryonic development.
Investigations of the influence of HS fi ne structure on affi nity for a given protein may be carried out in a variety of ways. Direct binding experiments involving the protein of interest and systematically modifi ed heparins (Ostrovsky et al. 2002) or heparan sulfate oligosaccharide libraries (Ashikari-Hada et al. 2004 ) can often be informative but recently the rapid rise of genomics and genetic manipulation has provided interesting and sometimes surprising evidence concerning the importance of specifi c substitution patterns in glycosaminoglycans. The enzymes which convert polymeric, unsulfated precursors (such as heparosan, Fig. 1B ) into the fully sulfated active sequences (such as those for heparin, Figs. 1A and 1C) have been especially informative (Kusche-Gullberg and Kjellen 2003, Nakato and Kimata 2002) . The sulfotransferases in particular may exist in several isoforms which are specifi c with respect to the type of sequence preferred as substrate. Expression of these isoforms, for example of HS6ST (heparan sulfate 6-O-sulfotransferase) and HS2ST (heparan sulfate 2-O-sulfotransferase), takes place in developing tissues in defi ned areas and at defi ned times ). This provides a mechanism by which specifi c affi nities of HS sequences for different growth factors and morphogens can form the gradients which give rise to correct formation of the developing embryo; for example in the nervous system (Bulow and Hobert 2004), heart (Yue et al. 2004) , limb buds (Berry et al. 2003 , Nogami et al. 2004 , and in cartilage (Kirn-Safran et al. 2004 ). In the kidney, absence of 2-O-sulfation leads to failure of kidney development: 2-O-desulfation impairs binding of heparin to glial cell line-derived neurotrophic factor (Rickard et al. 2003) .
It is also increasingly recognized that chondroitin sulfate sequences may display similar properties, being involved in development, nerve regen- and all contain the pattern of sulfates seen interacting with FGF-1 in the crystal structure (see Fig. 6 ). eration, and as pathogen receptors (Sugahara et al. 2003) .
Of course, the properties of heparan sulfate in regulation of cell growth and division have a negative side, and the role of heparan sulfate and extracellular heparanase in the growth of tumors has recently been reviewed (Sanderson et al. 2004 ). On the positive side, it is possible to look forward to the development of novel therapeutic agents which will surely be developed on the basis of our rapidly increasing understanding of the structural basis of heparan sulfate-protein interactions (Coombe and Kett 2005) .
CONCLUSIONS
Sulfation patterns alone can confer on a polysaccharide precise, physiologically important specifi city in interactions with proteins. Subtle variations in patterns of sulfation of glycosaminoglycans can modulate relative affi nities for information bearing extracellular proteins such as cytokines, growth factors and morphogens. This is the basis of their various functions in embryonic development and in tumor growth. 
